Annual CFI
$64.14 M
+$163.43 M+164.61%
December 31, 2023
Summary
- As of February 7, 2025, IKNA annual cash flow from investing activities is $64.14 million, with the most recent change of +$163.43 million (+164.61%) on December 31, 2023.
- During the last 3 years, IKNA annual CFI has risen by +$61.22 million (+2095.21%).
- IKNA annual CFI is now at all-time high.
Performance
IKNA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$9.45 M
+$5.54 M+141.30%
September 30, 2024
Summary
- As of February 7, 2025, IKNA quarterly cash flow from investing activities is $9.45 million, with the most recent change of +$5.54 million (+141.30%) on September 30, 2024.
- Over the past year, IKNA quarterly CFI has dropped by -$22.44 million (-70.36%).
- IKNA quarterly CFI is now -73.58% below its all-time high of $35.78 million, reached on September 30, 2022.
Performance
IKNA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$14.99 M
-$22.44 M-301.21%
September 30, 2024
Summary
- As of February 7, 2025, IKNA TTM cash flow from investing activities is -$14.99 million, with the most recent change of -$22.44 million (-301.21%) on September 30, 2024.
- Over the past year, IKNA TTM CFI has dropped by -$69.26 million (-127.62%).
- IKNA TTM CFI is now -123.37% below its all-time high of $64.14 million, reached on December 31, 2023.
Performance
IKNA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
IKNA Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +164.6% | -70.4% | -127.6% |
3 y3 years | +2095.2% | -58.3% | -125.8% |
5 y5 years | +10000.0% | -58.3% | -125.8% |
IKNA Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +164.6% | -73.6% | +105.7% | -123.4% | +91.0% |
5 y | 5-year | at high | +164.6% | -73.6% | +105.7% | -123.4% | +91.0% |
alltime | all time | at high | +164.6% | -73.6% | +105.7% | -123.4% | +91.0% |
Ikena Oncology Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $9.45 M(+141.3%) | -$14.99 M(-301.2%) |
Jun 2024 | - | $3.92 M(-108.0%) | $7.45 M(-71.6%) |
Mar 2024 | - | -$48.74 M(-339.2%) | $26.21 M(-59.1%) |
Dec 2023 | $64.14 M(-164.6%) | $20.38 M(-36.1%) | $64.14 M(+18.2%) |
Sep 2023 | - | $31.89 M(+40.6%) | $54.27 M(-6.7%) |
Jun 2023 | - | $22.68 M(-309.9%) | $58.16 M(+3.9%) |
Mar 2023 | - | -$10.81 M(-202.9%) | $55.96 M(-156.4%) |
Dec 2022 | -$99.28 M | $10.50 M(-70.7%) | -$99.28 M(-10.0%) |
Sep 2022 | - | $35.78 M(+74.7%) | -$110.33 M(-24.6%) |
Jun 2022 | - | $20.49 M(-112.3%) | -$146.30 M(-12.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$166.05 M(>+9900.0%) | -$166.97 M(+9387.0%) |
Dec 2021 | -$1.76 M(-160.2%) | -$550.00 K(+198.9%) | -$1.76 M(-196.3%) |
Sep 2021 | - | -$184.00 K(-1.6%) | $1.83 M(-9.1%) |
Jun 2021 | - | -$187.00 K(-77.7%) | $2.01 M(-8.5%) |
Mar 2021 | - | -$839.00 K(-127.6%) | $2.20 M(-24.7%) |
Dec 2020 | $2.92 M(-1024.7%) | $3.04 M(>+9900.0%) | $2.92 M(-2619.0%) |
Sep 2020 | - | $0.00(-100.0%) | -$116.00 K(0.0%) |
Jun 2020 | - | $1000.00(-100.9%) | -$116.00 K(-0.9%) |
Mar 2020 | - | -$117.00 K | -$117.00 K |
Dec 2019 | -$316.00 K | - | - |
FAQ
- What is Ikena Oncology annual cash flow from investing activities?
- What is the all time high annual CFI for Ikena Oncology?
- What is Ikena Oncology annual CFI year-on-year change?
- What is Ikena Oncology quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Ikena Oncology?
- What is Ikena Oncology quarterly CFI year-on-year change?
- What is Ikena Oncology TTM cash flow from investing activities?
- What is the all time high TTM CFI for Ikena Oncology?
- What is Ikena Oncology TTM CFI year-on-year change?
What is Ikena Oncology annual cash flow from investing activities?
The current annual CFI of IKNA is $64.14 M
What is the all time high annual CFI for Ikena Oncology?
Ikena Oncology all-time high annual cash flow from investing activities is $64.14 M
What is Ikena Oncology annual CFI year-on-year change?
Over the past year, IKNA annual cash flow from investing activities has changed by +$163.43 M (+164.61%)
What is Ikena Oncology quarterly cash flow from investing activities?
The current quarterly CFI of IKNA is $9.45 M
What is the all time high quarterly CFI for Ikena Oncology?
Ikena Oncology all-time high quarterly cash flow from investing activities is $35.78 M
What is Ikena Oncology quarterly CFI year-on-year change?
Over the past year, IKNA quarterly cash flow from investing activities has changed by -$22.44 M (-70.36%)
What is Ikena Oncology TTM cash flow from investing activities?
The current TTM CFI of IKNA is -$14.99 M
What is the all time high TTM CFI for Ikena Oncology?
Ikena Oncology all-time high TTM cash flow from investing activities is $64.14 M
What is Ikena Oncology TTM CFI year-on-year change?
Over the past year, IKNA TTM cash flow from investing activities has changed by -$69.26 M (-127.62%)